SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Small Cap Foreign Biotech
An SI Board Since January 2000
Posts SubjectMarks Bans
363 30 0
Emcee:  RWReeves Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
138I once had Evotech's homepage, and now I can't get anywhere finding the keokalani'nui-11/8/2000
137Noted this a little after the event... Still holding a small speculative positionigel bates-11/6/2000
136For some currencies, the Euro maybe slowed what would have otherwise have been akeokalani'nui-11/6/2000
135Those are some of my ADRs going out at 5 7/32 and 5 1/4. Nice 30% in a couple oscaram(o)uche-11/1/2000
134Hope anyone foolish enough to have bought any of these when I first mentioned thnigel bates-11/1/2000
133<i>Is there an equivalent of Edgar where I might search</i> It'nigel bates-10/31/2000
132Monday October 30,London - Antisoma plc (LSE:ASM, EASD:ASOM), the London-based bnigel bates-10/30/2000
131Here are the press releases for Procyon Biopharma,just in case you think I am a thebeach-10/29/2000
130If you are looking for well kept secrets in biotech here you go! Why it pays to thebeach-10/29/2000
129"LONDON, Oct 26 (Reuters) - Beleaguered British biotech company Cantab Plc nigel bates-10/26/2000
128<i>From most recent annual report - 'Cantab's proprietary OX4scaram(o)uche-10/18/2000
127Journal of Immunology Feb 15 2000, Vol 165 No4 "Engagement of the OX-40 Recnigel bates-10/18/2000
126It's way past my bedtime (g). I'll see if I can find out anything tomorrnigel bates-10/18/2000
125[ edit.... just found update in 9/6/00 interim report..... feel better ] Oucscaram(o)uche-10/18/2000
124I got a few of the ADRs at $4. I'm interested in the "human OX40"scaram(o)uche-10/18/2000
123I do wonder if the panning the stock took was a slight overreaction. There are anigel bates-10/18/2000
122Cantab... I think they designed their trial badly. You really don't want toRWReeves-10/18/2000
121The price of failure (latest installment) ... LONDON, Oct 18 (Reuters) - Shares nigel bates-10/18/2000
120LONDON, Oct 16 (Reuters) - UK biotechnology group Oxford Biomedica (LSE: OXB.L -nigel bates-10/16/2000
119For any of you following Procyon Biopharma: Procyon BioPharma Inc - Procyon nathebeach-10/12/2000
118To close the Genmab post... COPENHAGEN, Denmark, Oct. 11 /PRNewswire/ -- Genmabkeokalani'nui-10/11/2000
117Oct 9 (Reuters) - British biotechnology company ReNeuron Holdings Ltd said on Monigel bates-10/9/2000
116M&E Biotech. Early this year I was poking around the many IPOs. I rememberkeokalani'nui-10/6/2000
115Judging simply from what you posted, I am suspicious of anyone who crows about ekeokalani'nui-10/6/2000
114Can anyone figure out why this stock is not moving? Procyon BioPharma signs letthebeach-10/5/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News